(April 6, 2017) FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions. U.S. Food and Drug Administration press release. Available online at https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm551185.htm. Accessed on May 2, 2017.
April 6, 2017. F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers. New York Times. Available online at https://www.nytimes.com/2017/04/06/health/fda-genetic-tests-23andme.html. Accessed on May 2, 2017.
Phone call with Rachel Reichblum, spokesperson for 23andme. May 3, 2017.
Email exchange with Rachel Reichblum, spokesperson for 23andme. May 4, 2017.
(April 12, 2017) Freivogel, Mary E. FDA Approved 23andMe At-Home Genetic Tests: It's More Than "Just a Test". Available online at http://www.nsgc.org/p/bl/et/blogid=53&blogaid=898. Accessed May 18, 2017.
(©2017) 23andMe. Hereditary Thrombophilia. Available online at https://medical.23andme.org/wp-content/uploads/2017/04/VTE_one_F5_one_F2.pdf. Accessed May 2017.